We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

126 hedge funds and large institutions have $349M invested in Spectrum Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 34 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

47% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 34

6% more funds holding

Funds holding: 119126 (+7)

2% more capital invested

Capital invested by funds: $341M → $349M (+$8.35M)

21% less call options, than puts

Call options by funds: $1.86M | Put options by funds: $2.35M

Holders
126
Holders Change
+7
Holders Change %
+5.88%
% of All Funds
3.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
50
Reduced
34
Closed
8
Calls
$1.86M
Puts
$2.35M
Net Calls
-$483K
Net Calls Change
+$1.34M
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$2.36M +$30K +3,949 +1%
BA
27
Bard Associates
Illinois
$2.03M -$27.3K -3,600 -1%
Charles Schwab
28
Charles Schwab
California
$2.03M +$714K +94,086 +60%
BIM
29
BlackRock Investment Management
Delaware
$1.95M -$55.1K -7,263 -3%
Ameriprise
30
Ameriprise
Minnesota
$1.9M +$91.5K +12,060 +5%
Wells Fargo
31
Wells Fargo
California
$1.83M +$923K +121,666 +118%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$1.69M +$348K +45,804 +28%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$1.54M
Renaissance Technologies
34
Renaissance Technologies
New York
$1.51M +$111K +14,610 +9%
PP
35
PDT Partners
New York
$1.43M
Thrivent Financial for Lutherans
36
Thrivent Financial for Lutherans
Minnesota
$1.42M +$1.18M +155,100 +777%
DM
37
Deerfield Management
New York
$1.29M -$8.39M -1,106,253 -87%
Invesco
38
Invesco
Georgia
$1.22M -$186K -24,478 -14%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$1.09M +$856K +112,876 +545%
Morgan Stanley
40
Morgan Stanley
New York
$1.08M +$731K +96,287 +262%
STC
41
SEI Trust Company
Pennsylvania
$1.06M
Prudential Financial
42
Prudential Financial
New Jersey
$1.02M +$46.8K +6,164 +5%
IIM
43
Ironwood Investment Management
Massachusetts
$980K +$551K +72,669 +152%
Public Sector Pension Investment Board (PSP Investments)
44
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$979K +$73.6K +9,701 +9%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$973K +$35.7K +4,700 +4%
AIG
46
American International Group
New York
$972K +$539K +70,991 +146%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$944K -$30.3K -4,000 -3%
Jane Street
48
Jane Street
New York
$939K +$737K +97,153 +528%
ARTA
49
A.R.T. Advisors
New York
$873K -$234K -30,900 -22%
AllianceBernstein
50
AllianceBernstein
Tennessee
$870K

SPPI Hedge Fund Activity: Q2 2014 in Review

126 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2014, worth a combined $349M — up 2.4% from $341M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new SPPI positions and 8 closed out — a net gain of 8 holders — while 50 added to existing stakes and 34 trimmed.

The largest buyer was Bank of Montreal, adding an estimated $9.68M. The largest seller was Deerfield Management, cutting an estimated $8.39M.

  • 126 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2014, up from 119 in Q1 2014.
  • Funds reported $349M of Spectrum Pharmaceuticals Inc stock for Q2 2014, up 2.4% quarter-over-quarter.
  • 16 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2014 and 8 closed out, a net change of +8 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2014 was Bank of Montreal, an estimated $9.68M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2014 was Deerfield Management, an estimated $8.39M sold.

Based on aggregated 13F filings for Q2 2014.